[HTML][HTML] Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations

G Ferraioli, VWS Wong, L Castera, A Berzigotti… - Ultrasound in medicine …, 2018 - Elsevier
Abstract The World Federation for Ultrasound in Medicine and Biology has produced these
guidelines for the use of elastography techniques in liver diseases. For each available …

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression

R Waziry, B Hajarizadeh, J Grebely, J Amin, M Law… - Journal of …, 2017 - Elsevier
Background & Aims The risk of hepatocellular carcinoma (HCC) occurrence or recurrence
following direct-acting antiviral (DAA) hepatitis C virus (HCV) therapy remains unclear. The …

Global prevalence of celiac disease: systematic review and meta-analysis

P Singh, A Arora, TA Strand, DA Leffler… - Clinical …, 2018 - Elsevier
Background & Aims Celiac disease is a major public health problem worldwide. Although
initially it was reported from countries with predominant Caucasian populations, it now has …

Fibrosis regression after eradication of hepatitis C virus: from bench to bedside

DC Rockey, SL Friedman - Gastroenterology, 2021 - Elsevier
Hepatitis C virus (HCV) infection and its complications have been the major cause of
cirrhosis and its complications for several decades in the Western world. Until recently …

Global epidemiology, prevention, and management of hepatocellular carcinoma

LY Mak, V Cruz-Ramón, P Chinchilla-López… - American Society of …, 2018 - ascopubs.org
The incidence rate of hepatocellular carcinoma (HCC) is rising. It is one of the most common
cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B …

What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitis C virus infection?

GN Ioannou, JJ Feld - Gastroenterology, 2019 - Elsevier
Direct-acting antiviral (DAA) regimens are safe and effective at eradicating hepatitis C virus
(HCV) infection. Unfortunately, DAAs remain expensive, so treatment of all HCV-infected …

Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitis C: a systematic review and meta-analysis

S Singh, A Facciorusso, R Loomba… - Clinical Gastroenterology …, 2018 - Elsevier
Background & Aims We performed a systematic review and meta-analysis to estimate the
decrease in liver stiffness, measured by vibration-controlled transient elastrography (VCTE) …

[HTML][HTML] Cellular and molecular mechanisms underlying liver fibrosis regression

A Caligiuri, A Gentilini, M Pastore, S Gitto, F Marra - Cells, 2021 - mdpi.com
Chronic liver injury of different etiologies may result in hepatic fibrosis, a scar formation
process consisting in altered deposition of extracellular matrix. Progression of fibrosis can …

AGA clinical practice update on interaction between oral direct-acting antivirals for chronic hepatitis C infection and hepatocellular carcinoma: expert review

AG Singal, JK Lim, F Kanwal - Gastroenterology, 2019 - Elsevier
Description The purpose of this clinical practice update is to evaluate the evidence
describing the interaction between direct-acting antiviral (DAA) therapy for hepatitis and …

Noninvasive diagnostics for portal hypertension: a comprehensive review

M Mandorfer, V Hernández-Gea… - Seminars in liver …, 2020 - thieme-connect.com
Noninvasive diagnostics for portal hypertension include imaging and functional tests, as well
as blood-based biomarkers, and capture different features of the portal hypertensive …